Joined in 2023 
82 
63 About this deal
Certificates of Good Standing (dated within three months of the application date) if regulated by another regulator. out of 139 screening services submitted data, including 42 services that reported zero couples at risk. Please also read the general information relevant to all the NHS screening programme pathways. Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening Numerator: number of confirmed cytogenetic diagnoses of T21 following a higher chance T21 result from the quadruple test The chance cut-off is set at 1 in 150 at term for the combined and quadruple tests. This means women with a result of greater than or equal to 1 in 150 (between 1 in 2 and 1 in 150) are in the higher chance group. These women must be offered an appointment to discuss their results and the option of prenatal diagnosis. The appointment can be face to face or virtual depending on the woman’s choice.
NCARDRS use a multiple data source approach to improve data completeness and case ascertainment. Reporting period A sample can be tested for T21 only, T18 and T13 only, or all 3 conditions depending on the woman’s choice. Denominator: total number of T21, T18, T13 screening samples received in the screening laboratory in the reporting period These revised screening standards for the NHS fetal anomaly screening programme ( FASP) replace previous versions. They apply to data collected from 1 April 2022 unless stated otherwise in the document.
You will need an mySRA account to be able to log in and complete the application. Make changes to your anti-money laundering authorisation In Q4 2021 to 2022, national performance of FA4 for inadequate combined samples was 4.1%. FA4 is a KPI where a lower performance is better. Date standard last updated: April 2018 FASP-S03b: test: detection rate T21, T18, T13 screening Description Numerator: number of eligible babies who had a completed 20-week screening scan where the specified condition was suspected or confirmed.
present to the service (either dating scan or booking) with a CRL greater than 84.0mm (after 14 weeks plus 1 day) - some women may book and are thought to be before 14 weeks plus 2 days by last menstrual period ( LMP) but when scanned they are found to be at or after 14 weeks plus 2 days; these women can be excluded if there were no delays in the usual process of booking the dating scan Screening for 11 physical conditions as part of the 20-week scan is offered to all pregnant women and takes place between 18⁺⁰ and 20⁺⁶ weeks of pregnancy. Scans can be completed up to 23⁺⁰ weeks of pregnancy. Conditions screened for make sure all ultrasound practitioners involved in the pathway complete the e-learning resource First trimester resource for ultrasound practitioners every 12 monthsAcceptable level: 90.0% of rapid aneuploidy QFPCR results should be reported within 3 calendar days of sample receipt in the laboratory. A sample can be tested for Down’s syndrome only, Edwards’ syndrome and Patau’s syndrome only, or all 3 conditions depending on the woman’s choice. Denominator: number of samples for T21, T18, T13 screening received in the laboratory in the reporting period. The main aim of DQASS is to monitor and support the quality and effectiveness of Down’s syndrome, Edward’s syndrome and Patau’s syndrome screening in England. Workforce – education and training This standard monitors the true detection of the screening tests. This standard provides assurance that the screening tests are performing at optimal levels. Definition Down’s syndrome (T21) combined test
present to ultrasound with a CRL between 45.0mm and 84.0mm (at or after 11 weeks plus 2 days to before or at 14 weeks plus 1 day) where it was not technically possible to measure the nuchal translucency ( NT)National performance of ST4b (see standard STC-S05) in Q4 was 64.7%, lower than the previous quarter. The trend graph below shows England ST4b performance since the KPI was first published in Q1 2019 to 2020. Thresholds have not yet been set for this KPI. Denominator: number of women for whom a higher chance result (from the combined or quadruple test) is received by the maternity service in the reporting period. transfer in before or at 14 weeks plus 1 day of pregnancy ( CRL less than or equal to 84.0mm) who have a result from a screening test performed elsewhere in the NHS in this pregnancy Individuals who are not SRA-authorised need to register on mySRA before you send in your application.
National performance of FA2 (see standard FASP-SO2) in Q3 2021 to 2022 was 99.2%, the same as the previous quarter. FA2 is collected 6 months (2 quarters) in arrears. The trend graph below shows that England FA2 performance has remained above the achievable threshold of 95% since 1 April 2018.Sample did not have all data fields completed, as listed on the KPI template, to enable identification of the woman, analysis and reporting of results, including samples where the result needed recalculating after reporting. The numerator and denominator exclude congenitally corrected transposition of the great arteries ( TGA). For women having screening using the combined test, dependent of their screening choice, up to 2 results are reported: The proportion of women where an unexpected finding is suspected or confirmed in the baby at the 20-week screening scan.
Great Deal 
New Comment